lamictal 25mg dispersible tablets
sigma pharmaceuticals plc - lamotrigine - dispersible tablet - 25mg
lamictal 25mg dispersible tablets
lexon (uk) ltd - lamotrigine - dispersible tablet - 25mg
lamictal 25mg dispersible tablets
mawdsley-brooks & company ltd - lamotrigine - dispersible tablet - 25mg
lamictal 25mg dispersible tablets
stephar (u.k.) ltd - lamotrigine - dispersible tablet - 25mg
lamictal 25mg dispersible tablets
de pharmaceuticals - lamotrigine - dispersible tablet - 25mg
lamictal 5mg dispersible tablets
cst pharma ltd - lamotrigine - dispersible tablet - 5mg
lamictal 25mg dispersible tablets
cst pharma ltd - lamotrigine - dispersible tablet - 25mg
lamictal 5mg dispersible tablets
de pharmaceuticals - lamotrigine - dispersible tablet - 5mg
lamictal lamotrigine 5 mg dispersible/chewable tablet bottle
aspen pharmacare australia pty ltd - lamotrigine, quantity: 5 mg - tablet - excipient ingredients: calcium carbonate; hyprolose; aluminium magnesium silicate; sodium starch glycollate; povidone; saccharin sodium; magnesium stearate; flavour - lamictal is an anti-epileptic drug for the treatment of partial and generalised seizures in adults and children. there is extensive experience with lamictal used initially as ?add-on? therapy. the use of lamictal has also been found to be effective as monotherapy following withdrawal of concomitant anti-epileptic drugs. initial monotherapy treatment in newly diagnosed paediatric patients is not recommended (see clinical trials). lamictal is indicated for the prevention of depressive episodes in patients with bipolar disorder.
lamictal 2 mg chewable/dispersible tablets
glaxosmithkline (ireland) limited - lamotrigine - chewable/dispersible tablet - 2 milligram(s) - other antiepileptics; lamotrigine